Cue Biopharma (CUE) Total Assets (Quarterly): 30.71M

Cue Biopharma, Inc. (CUE)

20.03 +0.61 (+3.14%) USD | NASDAQ | Nov 03, 14:04

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2017. Start Trial.

Date	Value
June 30, 2026	30.71M
March 31, 2026	30.88M
December 31, 2025	43.14M
September 30, 2025	31.64M
June 30, 2025	40.71M
March 31, 2025	22.25M
December 31, 2024	32.19M
September 30, 2024	44.81M
June 30, 2024	42.33M
March 31, 2024	53.95M
December 31, 2023	61.53M
September 30, 2023	68.89M
June 30, 2023	73.16M
March 31, 2023	81.68M
December 31, 2022	91.28M
September 30, 2022	76.30M
June 30, 2022	84.75M
March 31, 2022	90.70M

Date	Value
December 31, 2021	83.40M
September 30, 2021	78.88M
June 30, 2021	89.67M
March 31, 2021	88.72M
December 31, 2020	99.53M
September 30, 2020	106.62M
June 30, 2020	101.35M
March 31, 2020	60.65M
December 31, 2019	71.60M
September 30, 2019	45.21M
June 30, 2019	41.76M
March 31, 2019	45.19M
December 31, 2018	45.36M
September 30, 2018	44.58M
June 30, 2018	53.11M
March 31, 2018	59.33M
December 31, 2017	66.95M
September 30, 2017	6.295M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks